Beam Therapeutics Inc BEAM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:13 PM EDT
22.75quote price arrow up+0.03 (+0.13%)
Volume
40,394
Close
22.72quote price arrow up+0.98 (+4.51%)
Volume
1,009,399
52 week range
16.95 - 49.50
Loading...
  • Open22.08
  • Day High23.06
  • Day Low22.00
  • Prev Close21.74
  • 52 Week High49.50
  • 52 Week High Date02/27/24
  • 52 Week Low16.95
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap1.87B
  • Shares Out82.31M
  • 10 Day Average Volume1.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-16.53

KEY STATS

  • Open22.08
  • Day High23.06
  • Day Low22.00
  • Prev Close21.74
  • 52 Week High49.50
  • 52 Week High Date02/27/24
  • 52 Week Low16.95
  • 52 Week Low Date10/23/23
  • Market Cap1.87B
  • Shares Out82.31M
  • 10 Day Average Volume1.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-16.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.87
  • P/E (TTM)-12.15
  • Fwd P/E (NTM)-4.12
  • EBITDA (TTM)-156.473M
  • ROE (TTM)-15.46%
  • Revenue (TTM)377.709M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-35.09%
  • Debt To Equity (MRQ)0.05%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beam Therapeutics Inc

 

Profile

MORE
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it...
John Evans
Chief Executive Officer, Director
Giuseppe Ciaramella Ph.D.
President
Terry-Ann Burrell
Chief Financial Officer, Treasurer
Address
238 Main Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
CPRX
Catalyst Pharmaceuticals Inc
15.02-0.18-1.18%
VCYT
Veracyte Inc
20.19+0.06+0.30%
TWST
Twist Bioscience Corp
32.01+0.05+0.16%
DNLI
Denali Therapeutics Inc
16.81+0.65+4.02%
ZLAB
Zai Lab Ltd
16.59+0.69+4.34%